gainbot
BriefMoversScreensSectorsEarningsIPOsNewsDividends & splitsScreenerWatchlistLearn
NASDAQ · NMTCHealthcareSurgical Instruments

NeuroOne Medical Technologies Corporation Common Stock (NMTC)

$0.9500−3.06%
Close Nov 4, 2026 · split-adjusted
Nov 4, 2026$0.95▼ 78.09% in range
Nov 4, 2025Low $0.80 · High $26.64Nov 4, 2026
What changed · written from our data
As of Nov 4, 2026

NeuroOne Medical Technologies closed at $0.95 on Nov 4, down 3.06%, 96.4% below its 52-week closing high. Volume of 93.6K shares was 0.99× its 20-day average (close to normal).

Split-adjusted performance: -15.9% over one month, -77.9% over six months, -79.3% over one year.

In the quarter ended Jun 30, 2026, revenue was $1.97M, up 16.3% from a year earlier, with a net margin of -101.7%.

Short interest was 207.3K shares at the Oct 15 settlement, up 16.0% from the prior report (2.8% of float, 1.0 days to cover).

Market cap$8.7M9.1M shares
Revenue · quarter$2.0M+16.3% YoY
Diluted EPS$-0.28—
P/E · TTM—P/S 0.7×
Net margin-101.7%Gross 59.9%
Dividend yieldNone
52-week range0.80 – 26.64−96.4% from high
Volume93.6K0.99× 20-day avg
Volatility · 60d99.1%Annualised
Short % of float2.8%1.0 days to cover
Net cash$2.0MCash $2.0M
Next earnings—Not scheduled
Split-adjusted performance
1W +10.7%1M −15.9%3M −38.7%6M −77.9%YTD −79.1%1Y −79.3%3Y −82.4%5Y −94.2%

Earnings reactions

History →

No reported quarters with price history yet.

Rank within Surgical Instruments

Percentile among 110 companies (100 = best)

6-month momentum8
Revenue growth68
Net margin23
Value (low P/E)—
Size15

Industry medians: 6-month return −4.0%, revenue growth +8.9%, net margin −8.2%, P/E 30.5×.

Short interest

Details →
Shares short207.3K+16.0% vs prior
Days to cover1.0Settled Oct 15
% of float2.8%
Short vol. 10d45.4%of daily volume

Closest peers by size in Surgical Instruments

CompanyPriceToday6MRev. growthNet marginP/EMkt cap
NMTCNeuroOne Medical Technologies$0.9500−3.06%−77.9%+16.3%−101.7%—$8.7M
ICUSeaStar Medical Holding$2.04+2.00%−58.1%+82.0%−606.5%—$10.8MCompare
CNSYCerenome$0.8916−31.42%————$6.8MCompare
FEMYFemasys$1.44+2.86%−84.1%−18.9%−1346.8%—$12.1MCompare
SINTSiNtx Technologies$1.66−3.49%−30.8%+199.3%−803.5%—$12.5MCompare
INBSIntelligent Bio Solutions$1.75−1.13%−27.4%+35.8%−341.0%—$5.8MCompare
GUTSFractyl Health$0.9725+8.27%−89.0%———$12.9MCompare
PAVMPAVmed$1.66−8.79%−76.3%+450.0%−16603.0%—$13.3MCompare
SNOASonoma Pharmaceuticals$1.11−2.63%−6.7%+59.6%−5.2%—$5.3MCompare

News about NeuroOne Medical Technologies

All news →

No recent articles focused on NeuroOne Medical Technologies.

Quick answers

What does NeuroOne Medical Technologies do?
NeuroOne Medical Technologies Corp is focused on diagnostic, ablation, and deep brain stimulation technology for brain-related conditions such as epilepsy and Parkinson's disease; ablation and stimulation for pain management; and drug delivery with diagnostic and stimulation capabilities. It develops thin film electrode technology for various recording and therapeutic applications, crucial for diagnosing neurological disorders such as epilepsy, Parkinson's disease, dystonia, and essential tremors.
What is NMTC's market cap?
$8.65M, based on the Nov 4 close of $0.95.
Does NeuroOne Medical Technologies pay a dividend?
No regular cash dividend has been paid in the last year.
How much of NMTC is sold short?
207.3K shares, 2.8% of float, as of Oct 15, 2026.
What sector is NMTC in?
Healthcare, in the Surgical Instruments industry.

About NeuroOne Medical Technologies

NeuroOne Medical Technologies Corp is focused on diagnostic, ablation, and deep brain stimulation technology for brain-related conditions such as epilepsy and Parkinson's disease; ablation and stimulation for pain management; and drug delivery with diagnostic and stimulation capabilities. It develops thin film electrode technology for various recording and therapeutic applications, crucial for diagnosing neurological disorders such as epilepsy, Parkinson's disease, dystonia, and essential tremors. The company operates in one segment, developing and commercializing products for neuromodulation, cEEG, and sEEG recording, monitoring, ablation, and brain stimulation, with revenue from Evo Cortical, Evo sEEG, and OneRF Ablation System.

HQ: Eden Prairie, MN18 employeesListed Nov 9, 2012n1mtc.com

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology